Cargando…
Finger and foot tapping as alternative outcomes of upper and lower extremity function in multiple sclerosis
BACKGROUND: While magnetic resonance imaging contrast-enhancing lesions represent an excellent screening tool for disease-modifying treatments in relapsing–remitting multiple sclerosis (RRMS), this biomarker is insensitive for testing therapies against compartmentalized inflammation in progressive m...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5480634/ https://www.ncbi.nlm.nih.gov/pubmed/28680701 http://dx.doi.org/10.1177/2055217316688930 |
_version_ | 1783245297580769280 |
---|---|
author | Tanigawa, Makoto Stein, Jason Park, John Kosa, Peter Cortese, Irene Bielekova, Bibiana |
author_facet | Tanigawa, Makoto Stein, Jason Park, John Kosa, Peter Cortese, Irene Bielekova, Bibiana |
author_sort | Tanigawa, Makoto |
collection | PubMed |
description | BACKGROUND: While magnetic resonance imaging contrast-enhancing lesions represent an excellent screening tool for disease-modifying treatments in relapsing–remitting multiple sclerosis (RRMS), this biomarker is insensitive for testing therapies against compartmentalized inflammation in progressive multiple sclerosis (MS). Therefore, alternative sensitive outcomes are needed. Using machine learning, clinician-acquired disability scales can be combined with timed measures of neurological functions such as walking speed (e.g. 25-foot walk; 25FW) or fine finger movements (e.g. 9-hole peg test; 9HPT) into sensitive composite clinical scales, such as the recently developed combinatorial, weight-adjusted disability scale (CombiWISE). Ideally, these complementary simplified measurements of certain neurological functions could be performed regularly at patients’ homes using smartphones. OBJECTIVES: We asked whether tests amenable to adaptation to smartphone technology, such as finger and foot tapping have comparable sensitivity and specificity to current non-clinician-acquired disability measures. RESULTS: We observed that finger and foot tapping can differentiate RRMS and progressive MS in a cross-sectional study and can also measure yearly and two-year disease progression in the latter, with better power (based on z-scores) in comparison to currently utilized 9HPT and 25FW. CONCLUSIONS: Replacing the 9HPT and 25FW with simplified tests broadly adaptable to smartphone technology may enhance the power of composite scales for progressive MS. |
format | Online Article Text |
id | pubmed-5480634 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-54806342017-07-05 Finger and foot tapping as alternative outcomes of upper and lower extremity function in multiple sclerosis Tanigawa, Makoto Stein, Jason Park, John Kosa, Peter Cortese, Irene Bielekova, Bibiana Mult Scler J Exp Transl Clin Original Article BACKGROUND: While magnetic resonance imaging contrast-enhancing lesions represent an excellent screening tool for disease-modifying treatments in relapsing–remitting multiple sclerosis (RRMS), this biomarker is insensitive for testing therapies against compartmentalized inflammation in progressive multiple sclerosis (MS). Therefore, alternative sensitive outcomes are needed. Using machine learning, clinician-acquired disability scales can be combined with timed measures of neurological functions such as walking speed (e.g. 25-foot walk; 25FW) or fine finger movements (e.g. 9-hole peg test; 9HPT) into sensitive composite clinical scales, such as the recently developed combinatorial, weight-adjusted disability scale (CombiWISE). Ideally, these complementary simplified measurements of certain neurological functions could be performed regularly at patients’ homes using smartphones. OBJECTIVES: We asked whether tests amenable to adaptation to smartphone technology, such as finger and foot tapping have comparable sensitivity and specificity to current non-clinician-acquired disability measures. RESULTS: We observed that finger and foot tapping can differentiate RRMS and progressive MS in a cross-sectional study and can also measure yearly and two-year disease progression in the latter, with better power (based on z-scores) in comparison to currently utilized 9HPT and 25FW. CONCLUSIONS: Replacing the 9HPT and 25FW with simplified tests broadly adaptable to smartphone technology may enhance the power of composite scales for progressive MS. SAGE Publications 2017-01-01 /pmc/articles/PMC5480634/ /pubmed/28680701 http://dx.doi.org/10.1177/2055217316688930 Text en © The Author(s) 2017 http://creativecommons.org/licenses/by-nc/3.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Original Article Tanigawa, Makoto Stein, Jason Park, John Kosa, Peter Cortese, Irene Bielekova, Bibiana Finger and foot tapping as alternative outcomes of upper and lower extremity function in multiple sclerosis |
title | Finger and foot tapping as alternative outcomes of upper and lower extremity function in multiple sclerosis |
title_full | Finger and foot tapping as alternative outcomes of upper and lower extremity function in multiple sclerosis |
title_fullStr | Finger and foot tapping as alternative outcomes of upper and lower extremity function in multiple sclerosis |
title_full_unstemmed | Finger and foot tapping as alternative outcomes of upper and lower extremity function in multiple sclerosis |
title_short | Finger and foot tapping as alternative outcomes of upper and lower extremity function in multiple sclerosis |
title_sort | finger and foot tapping as alternative outcomes of upper and lower extremity function in multiple sclerosis |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5480634/ https://www.ncbi.nlm.nih.gov/pubmed/28680701 http://dx.doi.org/10.1177/2055217316688930 |
work_keys_str_mv | AT tanigawamakoto fingerandfoottappingasalternativeoutcomesofupperandlowerextremityfunctioninmultiplesclerosis AT steinjason fingerandfoottappingasalternativeoutcomesofupperandlowerextremityfunctioninmultiplesclerosis AT parkjohn fingerandfoottappingasalternativeoutcomesofupperandlowerextremityfunctioninmultiplesclerosis AT kosapeter fingerandfoottappingasalternativeoutcomesofupperandlowerextremityfunctioninmultiplesclerosis AT corteseirene fingerandfoottappingasalternativeoutcomesofupperandlowerextremityfunctioninmultiplesclerosis AT bielekovabibiana fingerandfoottappingasalternativeoutcomesofupperandlowerextremityfunctioninmultiplesclerosis |